Cartesian Growth Corp. Iv (CGCF) vs Translational Development Acquisition Corp. (TDAC)

A side-by-side comparison of Cartesian Growth Corp. Iv and Translational Development Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CGCF

Cartesian Growth Corp. Iv

$270M

$9.82Financial ServicesDelayed quote: Oct 6, 2026, 10:30 AM EDT

TDAC

Translational Development Acquisition Corp.

$266M

$10.82Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CGCF vs TDAC

growth of $100 · dividends reinvested · last 1y

CGCF -1.4% (-1.4%/yr)TDAC -0.2% (-0.2%/yr)TDAC compounded faster over this window

CGCF TDAC

Metrics side by side

Total return (annualized)

Metric	CGCF	TDAC
Total return (1Y)	N/A	4.72%

CGCF is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CGCF analysis Full TDAC analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.